We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $163M
1-Year Est. Return 240.43%
This Fund
S&P 500
This Quarter Est. Return
+36.78%
1 Year Est. Return
+240.43%
3 Year Est. Return
+409.28%
5 Year Est. Return
+142.09%
10 Year Est. Return
+4,071.98%
AUM
$171M
AUM Growth
-$3.46M
Cap. Flow
-$137K
Cap. Flow %
-0.08%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$137K

Sector Composition

Rank Sector Weight
1 Healthcare 97.74%
2 Miscellaneous 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GKOS icon
1
Glaukos
GKOS
$10.1B
$77.6M 45.39%
3,136,232
-5,985
-0.2% -$137K
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$45.3M 26.52%
1,092,152
– –
OCUL icon
3
Ocular Therapeutix
OCUL
$2.24B
$20.8M 12.15%
2,215,384
– –
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
$14.3M 8.34%
407,416
– –
AKAO
5
DELISTED
Achaogen Inc
AKAO
$7.35M 4.3%
1,281,152
– –
BITI
6
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
$3.86M 2.26%
268,672
– –
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$1.77M 1.04%
1,048,601
– –

Similar funds

TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GF
Gimbal Financial Carmel, Indiana $163M AUM
ACM
Arrington Capital Management Miami, Florida $163M AUM
KFS
Krane Financial Solutions Calabasas, California $162M AUM
VB
Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return
RWA
Reicon Wealth Advisors Atlanta, Georgia $162M AUM
CCM
Candelo Capital Management New York $162M AUM 112.87% 1-Year Est. Return
GCM
Generation Capital Management Pittsford, New York $163M AUM 42.22% 1-Year Est. Return

Versant Venture Management's Q4 2015 Portfolio in Review

As of Q4 2015, Versant Venture Management held 7 positions worth $171M, down 2% from $174M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2015: portfolio turnover was 0%. Versant Venture Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 98% a quarter earlier, followed by Miscellaneous.

  • Versant Venture Management's biggest Q4 2015 reduction was Glaukos, cutting an estimated $137K.
  • Versant Venture Management's ten largest holdings make up 100% of its $171M portfolio in Q4 2015.
  • Versant Venture Management opened 0 new positions and closed 0 in Q4 2015.
  • Versant Venture Management's portfolio value fell 2% quarter-over-quarter to $171M.

Based on Versant Venture Management's 13F filing for Q4 2015, filed 10 Feb 2016.